NCT06949670View on ClinicalTrials.gov

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2028

Study Completion Date

April 1, 2028

Conditions
Alpha Synuclein PathologyAlpha-SynucleinParkinson Disease
Interventions
DIAGNOSTIC_TEST

18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06

Each subject receive a single intravenous injection of 18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06 and undergo PET/CT or MRI imaging within the specificed time.

Trial Locations (1)

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER